Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05785208
Title Efficacy Study of Osimertinib in Treatment-naïve Patients With EGFR Mutant NSCLC According to TP53 Mutational Status. (TEMPLE-2)
Acronym TEMPLE-2
Recruitment Recruiting
Gender both
Phase FDA approved
Variant Requirements No
Sponsors Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Indications
Therapies
Age Groups: senior | adult
Covered Countries ITA

Facility Status City State Zip Country Details
Azienda Ospedaliero-Universitaria Ospedali Riuniti SUSPENDED Ancona 60020 Italy Details
IRCCS Istituto Tumori Giovanni Paolo II SUSPENDED Bari 70124 Italy Details
Azienda Ospedaliero-Universitaria Careggi SUSPENDED Firenze 50134 Italy Details
Ospedale Universitario di Parma SUSPENDED Parma 44129 Italy Details
Ospedale San Camillo de Lellis SUSPENDED Rieti 02100 Italy Details
Università Policlinico Tor Vergata SUSPENDED Rome 00133 Italy Details
Policlinico Umberto I SUSPENDED Rome 00161 Italy Details
Fondazione Policlinico Gemelli IRCCS RECRUITING Rome 00168 Italy Details
Ospedale San Giovanni-Addolorata SUSPENDED Rome 00184 Italy Details
Ospedale San Luigi SUSPENDED Turin 10043 Italy Details
Università degli Studi di Verona SUSPENDED Verona 37129 Italy Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field